Diagnosis and management of subcutaneous implantable cardioverter-defibrillator infections based on process mapping
© 2020 Wiley Periodicals LLC..
BACKGROUND: Infection is a well-recognized complication of cardiovascular implantable electronic device (CIED) implantation, including the more recently available subcutaneous implantable cardioverter-defibrillator (S-ICD). Although the AHA/ACC/HRS guidelines include recommendations for S-ICD use, currently there are no clinical trial data that address the diagnosis and management of S-ICD infections. Therefore, an expert panel was convened to develop consensus on these topics.
METHODS: A process mapping methodology was used to achieve a primary goal - the development of consensus on the diagnosis and management of S-ICD infections. Two face-to-face meetings of panel experts were conducted to recommend useful information to clinicians in individual patient management of S-ICD infections.
RESULTS: Panel consensus of a stepwise approach in the diagnosis and management was developed to provide guidance in individual patient management.
CONCLUSION: Achieving expert panel consensus by process mapping methodology in S-ICD infection diagnosis and management was attainable, and the results should be helpful in individual patient management.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
Pacing and clinical electrophysiology : PACE - 43(2020), 9 vom: 15. Sept., Seite 958-965 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Baddour, Larry M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibiotics |
|---|
| Anmerkungen: |
Date Completed 12.10.2021 Date Revised 12.10.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/pace.13902 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM308531825 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM308531825 | ||
| 003 | DE-627 | ||
| 005 | 20231225131929.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/pace.13902 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1028.xml |
| 035 | |a (DE-627)NLM308531825 | ||
| 035 | |a (NLM)32267974 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Baddour, Larry M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Diagnosis and management of subcutaneous implantable cardioverter-defibrillator infections based on process mapping |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.10.2021 | ||
| 500 | |a Date Revised 12.10.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 Wiley Periodicals LLC. | ||
| 520 | |a BACKGROUND: Infection is a well-recognized complication of cardiovascular implantable electronic device (CIED) implantation, including the more recently available subcutaneous implantable cardioverter-defibrillator (S-ICD). Although the AHA/ACC/HRS guidelines include recommendations for S-ICD use, currently there are no clinical trial data that address the diagnosis and management of S-ICD infections. Therefore, an expert panel was convened to develop consensus on these topics | ||
| 520 | |a METHODS: A process mapping methodology was used to achieve a primary goal - the development of consensus on the diagnosis and management of S-ICD infections. Two face-to-face meetings of panel experts were conducted to recommend useful information to clinicians in individual patient management of S-ICD infections | ||
| 520 | |a RESULTS: Panel consensus of a stepwise approach in the diagnosis and management was developed to provide guidance in individual patient management | ||
| 520 | |a CONCLUSION: Achieving expert panel consensus by process mapping methodology in S-ICD infection diagnosis and management was attainable, and the results should be helpful in individual patient management | ||
| 650 | 4 | |a Consensus Development Conference | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a antibiotics | |
| 650 | 4 | |a diagnosis | |
| 650 | 4 | |a extraction | |
| 650 | 4 | |a infection | |
| 650 | 4 | |a mapping | |
| 650 | 4 | |a subcutaneous implantable cardioverter-defibrillator | |
| 700 | 1 | |a Weiss, Raul |e verfasserin |4 aut | |
| 700 | 1 | |a Mark, George E |e verfasserin |4 aut | |
| 700 | 1 | |a El-Chami, Mikhael F |e verfasserin |4 aut | |
| 700 | 1 | |a Biffi, Mauro |e verfasserin |4 aut | |
| 700 | 1 | |a Probst, Vincent |e verfasserin |4 aut | |
| 700 | 1 | |a Lambiase, Pier D |e verfasserin |4 aut | |
| 700 | 1 | |a Miller, Marc A |e verfasserin |4 aut | |
| 700 | 1 | |a McClernon, Timothy |e verfasserin |4 aut | |
| 700 | 1 | |a Hansen, Linda K |e verfasserin |4 aut | |
| 700 | 1 | |a Knight, Bradley P |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pacing and clinical electrophysiology : PACE |d 1983 |g 43(2020), 9 vom: 15. Sept., Seite 958-965 |w (DE-627)NLM000837431 |x 1540-8159 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2020 |g number:9 |g day:15 |g month:09 |g pages:958-965 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/pace.13902 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2020 |e 9 |b 15 |c 09 |h 958-965 | ||